Joint statement to Prime Minister Abe from JPMA, IFPMA, PhRMA and EFPIA
Read moreIFPMA, supported by ICBA, share the goal of WHO and its Members to ensure appropriate access to affordable and quality-assured medicines and vaccines as a key component of UHC. We appreciate WHO’s efforts to develop the Roadmap, which could be a useful tool in providing greater clarity between various activities by the Organization. We also...
Read moreSeasonal influenza virus sharing is being negatively impacted due to the national implementation of the Protocol in some countries. Delayed sharing can challenge the timely supply of vaccines and the ability of GISRS to ensure that well-matched vaccines are developed and to rapidly detect the emergence of pandemic influenza strains. Attaching benefits to the existence of...
Read moreSeasonal influenza virus sharing is already being negatively impacted by national implementation of the Nagoya Protocol in some countries. Several instances have been reported by the WHO Collaborating Centers where countries have delayed, or stopped altogether, the sharing of seasonal influenza virus samples on the grounds of conflict with local access and benefit sharing legislation,...
Read moreIFPMA stands together with the global health community to support Member States in accelerating efforts to achieve UHC. We also welcome the recognition that UHC must include access to affordable and quality-assured medicines, vaccines and health products. Through our work in novel partnerships with governments, NGOs, and private sector entities, the industry is supporting UHC...
Read moreAdebayo Alonge, pharmacist and entrepreneur, talks to IFPMA about why it is important to bring universal health coverage (UHC) to his native Africa, especially rural areas, how to build up local healthcare systems, foster home-grown hi-tech pharma – and fight quack medicines. You have been an avid global health advocate with a specific focus...
Read moreThis blog was originally published on Health Policy Watch on 10 May 2019. “Most of us can probably agree that innovation is meaningless if it does not reach patients. At the same time, a Fair Price must strike a balance between a price that is affordable for health systems and patients, while incentivizing investments into...
Read moreThis article was originally published by Business Day on April 16, 2019. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) says health activists’ call last week for greater transparency on medicine prices could backfire, and drive up drug costs in low and middle-income countries. Activists stepped up their campaign ahead of the Fair Pricing...
Read moreThis article was originally published by STAT on April 16, 2019. Vaccines are credited with averting millions of child deaths in the last decade, with most countries offering infants the basic protection of immunization against more than 10 serious diseases. But the risk of infectious disease does not end with childhood: there are clear opportunities...
Read moreAs the number of infections resistant to antimicrobial drugs continues to rise around the world, and with it their huge human and financial toll, we urgently need new ways to preserve the effectiveness of existing antibiotics and to develop much-needed new ones. Creating state-run or publicly owned pharmaceutical companies, an idea promoted last week by...
Read moreMore and more, Africans and their leaders, public and private, can see that good health is a key, perhaps the key, to a healthy and sustainable economy. And that universal health coverage (UHC), quality healthcare for all, can unlock the huge potential of 1.3bn people as I and others heard at the recent World Health...
Read moreThe announcement by Facebook that it will no longer allow anti-vaccine advertisements on its platform is welcome as measles cases surge in the U.S. Pacific Northwest and double in Europe. But this measure alone is not enough to address the growing global spread of “vaccine hesitancy” and rising rates of disease and death caused by undervaccination. Facebook has pledged to address some...
Read more